Overview
Azalea Vision builds computer vision technology for applied use cases where automated visual understanding drives operational value. The EUR 9M Series A, closed in H1 2025, positions the company to scale its technology and expand its customer base.
Computer vision remains one of the most commercially mature segments of applied AI, and Azalea Vision competes alongside Belgian peers such as Robovision and Azalea Vision in delivering domain-specific visual intelligence.
Funding & milestones
1 events found for Azalea Vision · 2025
Series AVenture / equityDetailsEUR 9M
Reported amount EUR 9,000,000
Source not attached to this recordDeal record
Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.
Profile narrative
- Series A: EUR 9M (H1 2025)
Key people
In the news
- Azalea Vision is entering its clinical phase with a leadership transition among its co-founders. Co-founder Andrés Vásquez Quintero, inventor of our adaptive-optics platform, is taking on the role of CEO while continuing as CTO. Co-founder Enrique Vega, our founding CEO, moves to the Board of Directors, where he'll continue to support our strategy and long-term vision. The move aligns our leadership with what comes next: advancing our smart contact lens platform into clinical development, following our selection for the EIC -
- Europese miljoenen voor Gentse contactlens vol nanotechnologie16:49 Azalea Vision krijgt van de European Innovation Council 7,5 miljoen euro vers geld toegewezen. Het Gentse medtechbedrijf ontwikkelde een slimme contactlens om oogziektes te behandelen en glucose op te...
De Tijd Farma · 21 Jul 2026
- Exciting News: Azalea Vision Vision has been awarded up to €7.5M in blended finance from the prestigious EIC - European Innovation Council Accelerator! Fewer than 5% of applicants succeed in this flagship EU program. This milestone provides powerful validation of our technology, clinical strategy, and market potential as we advance our smart contact lens platform into clinical development. The Technology: Born as an imec and Ghent University spin-off, we are building a medical-grade smart lens designed to correct complex
- We are proud to announce that Azalea Vision has been selected by the EIC Accelerator for blended finance support, with access to a €2.5 million grant and expected €5 million equity participation from the EIC Fund in our next financing round. This is a major milestone for Azalea. It validates what we have been building since the beginning: a medical-grade smart lens platform that brings together adaptive optics, embedded microelectronics, liquid-crystal systems, and connectivity inside a contact lens format. This recognition
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.